Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone acetyltransferase activity	NCOA3 KAT2A SRCAP CREBBP TAF9	1.36e-05	51	120	5	GO:0004402
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	NCOA3 KAT2A SRCAP CREBBP TAF9	1.97e-05	55	120	5	GO:0061733
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	NCOA3 KAT2A SRCAP CREBBP TAF9	3.02e-05	60	120	5	GO:0034212
GeneOntologyMolecularFunction	histone modifying activity	NCOA3 KAT2A KDM6B SRCAP CREBBP JAK2 SETBP1 TAF9	7.39e-05	229	120	8	GO:0140993
GeneOntologyMolecularFunction	histone H3K18 acetyltransferase activity	KAT2A CREBBP	1.07e-04	3	120	2	GO:0043993
GeneOntologyMolecularFunction	N-acetyltransferase activity	NCOA3 KAT2A SRCAP CREBBP TAF9	1.07e-04	78	120	5	GO:0008080
GeneOntologyMolecularFunction	structural constituent of synapse	SHANK2 RIMS1 CTNND2 BSN	1.16e-04	42	120	4	GO:0098918
GeneOntologyMolecularFunction	very-low-density lipoprotein particle receptor activity	LDLR LRP8	2.13e-04	4	120	2	GO:0030229
GeneOntologyMolecularFunction	N-acyltransferase activity	NCOA3 KAT2A SRCAP CREBBP TAF9	3.77e-04	102	120	5	GO:0016410
GeneOntologyMolecularFunction	acetyltransferase activity	NCOA3 KAT2A SRCAP CREBBP TAF9	4.13e-04	104	120	5	GO:0016407
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA3 POU2AF1 TSG101 KAT2A SRCAP CREBBP TSC22D1 TAF9	4.96e-04	303	120	8	GO:0003713
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	NCOA3 DLG5 GATAD2A ANK2 RBM33 POU2AF1 TSG101 KAT2A RUNX1T1 SRCAP WNK1 CREBBP GAS2L1 TSC22D1 SHANK2 TAF9 HCLS1	5.68e-04	1160	120	17	GO:0030674
GeneOntologyMolecularFunction	beta-catenin binding	DLG5 KDM6B TJP1 DCHS1 CTNND2	7.92e-04	120	120	5	GO:0008013
GeneOntologyMolecularFunction	extracellular matrix structural constituent	HSPG2 FN1 COL27A1 MUC5AC MUC6 NPNT	9.67e-04	188	120	6	GO:0005201
GeneOntologyMolecularFunction	structural constituent of presynaptic active zone	RIMS1 BSN	9.79e-04	8	120	2	GO:0098882
GeneOntologyMolecularFunction	molecular adaptor activity	NCOA3 DLG5 GATAD2A ANK2 RBM33 POU2AF1 TSG101 KAT2A RUNX1T1 SRCAP WNK1 CREBBP LDLR GAS2L1 TSC22D1 SHANK2 TAF9 HCLS1	1.22e-03	1356	120	18	GO:0060090
GeneOntologyMolecularFunction	collagen binding	HSPG2 FN1 PAK1 USH2A	1.44e-03	81	120	4	GO:0005518
GeneOntologyMolecularFunction	structural constituent of postsynaptic density	SHANK2 CTNND2	1.90e-03	11	120	2	GO:0098919
GeneOntologyMolecularFunction	clathrin heavy chain binding	PLK2 LDLR	2.27e-03	12	120	2	GO:0032050
GeneOntologyBiologicalProcess	dendritic spine development	EPHB3 DLG5 PLK2 CREBBP LRP8 PAK1 CTNND2	1.78e-05	141	119	7	GO:0060996
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	3.30e-05	2	119	2	GO:0036309
GeneOntologyBiologicalProcess	cognition	PLK2 KAT2A SPECC1 CREBBP LDLR CIC SHANK2 PAK1 ANKRD11 LRRN4 CTNND2	3.43e-05	423	119	11	GO:0050890
GeneOntologyBiologicalProcess	learning or memory	PLK2 KAT2A SPECC1 CREBBP LDLR CIC SHANK2 PAK1 LRRN4 CTNND2	6.14e-05	373	119	10	GO:0007611
GeneOntologyCellularComponent	Golgi lumen	HSPG2 MUC19 MUC16 MUC5B MUC12 MUC5AC MUC6	3.34e-06	109	121	7	GO:0005796
GeneOntologyCellularComponent	Hrd1p ubiquitin ligase complex	SYVN1 FAM8A1	1.98e-04	4	121	2	GO:0000836
GeneOntologyCellularComponent	postsynaptic density	DLG5 ANK2 LRP8 SHANK2 CELSR3 PAK1 ROBO2 RIMS1 CTNND2 BSN	2.97e-04	451	121	10	GO:0014069
GeneOntologyCellularComponent	ER ubiquitin ligase complex	SYVN1 FAM8A1	3.29e-04	5	121	2	GO:0000835
GeneOntologyCellularComponent	asymmetric synapse	DLG5 ANK2 LRP8 SHANK2 CELSR3 PAK1 ROBO2 RIMS1 CTNND2 BSN	4.61e-04	477	121	10	GO:0032279
GeneOntologyCellularComponent	intercalated disc	ANK2 OBSCN TJP1 PAK1	6.54e-04	68	121	4	GO:0014704
GeneOntologyCellularComponent	postsynaptic specialization	DLG5 ANK2 LRP8 SHANK2 CELSR3 PAK1 ROBO2 RIMS1 CTNND2 BSN	6.94e-04	503	121	10	GO:0099572
GeneOntologyCellularComponent	glutamatergic synapse	CACNB1 DLG5 MYO9A LRP8 JAK2 SHANK2 CELSR3 PAK1 ROBO2 RIMS1 CTNND2 BSN DNM1	9.07e-04	817	121	13	GO:0098978
GeneOntologyCellularComponent	Derlin-1 retrotranslocation complex	HM13 SYVN1	9.09e-04	8	121	2	GO:0036513
GeneOntologyCellularComponent	cytoskeleton of presynaptic active zone	RIMS1 BSN	9.09e-04	8	121	2	GO:0048788
GeneOntologyCellularComponent	neuron to neuron synapse	DLG5 ANK2 LRP8 SHANK2 CELSR3 PAK1 ROBO2 RIMS1 CTNND2 BSN	9.34e-04	523	121	10	GO:0098984
GeneOntologyCellularComponent	histone deacetylase complex	GATAD2A EP400 SRCAP SAP130	1.51e-03	85	121	4	GO:0000118
GeneOntologyCellularComponent	actin filament	MYO9A SPECC1 GAS2L1 PAK1 HCLS1	1.61e-03	146	121	5	GO:0005884
HumanPheno	Hip dysplasia	HSPG2 MYO9A SRCAP CREBBP CASZ1 ZNF469 SETBP1 ANKRD11 MBD5 PIGO	1.10e-05	247	39	10	HP:0001385
Domain	C8	MUC19 MUC5B MUC5AC MUC6 OTOG	7.37e-09	12	119	5	PF08742
Domain	TIL	MUC19 MUC5B MUC5AC MUC6 OTOG	7.37e-09	12	119	5	PF01826
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B MUC5AC MUC6 OTOG	1.19e-08	13	119	5	IPR014853
Domain	C8	MUC19 MUC5B MUC5AC MUC6 OTOG	1.19e-08	13	119	5	SM00832
Domain	TIL_dom	MUC19 MUC5B MUC5AC MUC6 OTOG	1.85e-08	14	119	5	IPR002919
Domain	VWF_type-D	MUC19 MUC5B MUC5AC MUC6 OTOG	3.98e-08	16	119	5	IPR001846
Domain	VWFD	MUC19 MUC5B MUC5AC MUC6 OTOG	3.98e-08	16	119	5	PS51233
Domain	VWD	MUC19 MUC5B MUC5AC MUC6 OTOG	3.98e-08	16	119	5	SM00216
Domain	VWD	MUC19 MUC5B MUC5AC MUC6 OTOG	3.98e-08	16	119	5	PF00094
Domain	VWC_out	MUC19 MUC5B MUC5AC MUC6 OTOG	1.04e-07	19	119	5	SM00215
Domain	CT	MUC19 MUC5B MUC5AC MUC6 OTOG	2.33e-07	22	119	5	SM00041
Domain	Cys_knot_C	MUC19 MUC5B MUC5AC MUC6 OTOG	4.63e-07	25	119	5	IPR006207
Domain	CTCK_2	MUC19 MUC5B MUC5AC MUC6 OTOG	4.63e-07	25	119	5	PS01225
Domain	VWF_dom	MUC19 MUC5B MUC5AC MUC6 OTOG	6.80e-06	42	119	5	IPR001007
Domain	fn3	EPHB3 FN1 OBSCN FNDC1 CSF3R ROBO2 LRRN4 USH2A	9.35e-06	162	119	8	PF00041
Domain	-	HSPG2 TMPRSS9 TMPRSS13 LDLR LRP8	1.07e-05	46	119	5	4.10.400.10
Domain	LDLRA_1	HSPG2 TMPRSS9 TMPRSS13 LDLR LRP8	1.33e-05	48	119	5	PS01209
Domain	LDrepeatLR_classA_rpt	HSPG2 TMPRSS9 TMPRSS13 LDLR LRP8	1.47e-05	49	119	5	IPR002172
Domain	LDLa	HSPG2 TMPRSS9 TMPRSS13 LDLR LRP8	1.47e-05	49	119	5	SM00192
Domain	LDLRA_2	HSPG2 TMPRSS9 TMPRSS13 LDLR LRP8	1.47e-05	49	119	5	PS50068
Domain	FN3	EPHB3 FN1 OBSCN FNDC1 CSF3R ROBO2 LRRN4 USH2A	2.45e-05	185	119	8	SM00060
Domain	EGF_1	HSPG2 FN1 MUC12 LDLR LRP8 CELSR3 DLK2 USH2A NPNT	3.75e-05	255	119	9	PS00022
Domain	SM_dom_ATX	ATXN2L ATXN2	4.03e-05	2	119	2	IPR025852
Domain	LsmAD	ATXN2L ATXN2	4.03e-05	2	119	2	PF06741
Domain	LsmAD_domain	ATXN2L ATXN2	4.03e-05	2	119	2	IPR009604
Domain	LsmAD	ATXN2L ATXN2	4.03e-05	2	119	2	SM01272
Domain	SM-ATX	ATXN2L ATXN2	4.03e-05	2	119	2	PF14438
Domain	FN3	EPHB3 FN1 OBSCN FNDC1 CSF3R ROBO2 LRRN4 USH2A	4.12e-05	199	119	8	PS50853
Domain	FN3_dom	EPHB3 FN1 OBSCN FNDC1 CSF3R ROBO2 LRRN4 USH2A	5.83e-05	209	119	8	IPR003961
Domain	LAM_G_DOMAIN	HSPG2 COL27A1 CELSR3 USH2A	9.78e-05	38	119	4	PS50025
Domain	EGF_CA	HSPG2 LDLR LRP8 CELSR3 DLK2 NPNT	1.31e-04	122	119	6	SM00179
Domain	EGF-like_Ca-bd_dom	HSPG2 LDLR LRP8 CELSR3 DLK2 NPNT	1.43e-04	124	119	6	IPR001881
Domain	Ldl_recept_a	HSPG2 TMPRSS9 LDLR LRP8	1.91e-04	45	119	4	PF00057
Domain	CTCK_1	MUC19 MUC5B MUC5AC	1.92e-04	18	119	3	PS01185
Domain	TSC-22_Dip_Bun	TSC22D2 TSC22D1	2.40e-04	4	119	2	IPR000580
Domain	HSA	EP400 SRCAP	2.40e-04	4	119	2	SM00573
Domain	TSC-22_Dip_Bun	TSC22D2 TSC22D1	2.40e-04	4	119	2	PD007152
Domain	HSA	EP400 SRCAP	2.40e-04	4	119	2	PS51204
Domain	TSC22	TSC22D2 TSC22D1	2.40e-04	4	119	2	PF01166
Domain	HSA_dom	EP400 SRCAP	2.40e-04	4	119	2	IPR014012
Domain	HSA	EP400 SRCAP	2.40e-04	4	119	2	PF07529
Domain	TSC22	TSC22D2 TSC22D1	2.40e-04	4	119	2	PS01289
Domain	EGF-like_CS	HSPG2 FN1 MUC12 LDLR LRP8 CELSR3 DLK2 NPNT	2.69e-04	261	119	8	IPR013032
Domain	SEA	HSPG2 MUC16 MUC12	3.56e-04	22	119	3	PF01390
Domain	SAM	EPHB3 ZCCHC14 ARAP3 SHANK2 CASKIN2	3.90e-04	97	119	5	IPR001660
Domain	SEA	HSPG2 MUC16 MUC12	4.07e-04	23	119	3	PS50024
Domain	SEA_dom	HSPG2 MUC16 MUC12	4.07e-04	23	119	3	IPR000082
Domain	ASX_HYDROXYL	LDLR LRP8 CELSR3 DLK2 NPNT	4.49e-04	100	119	5	PS00010
Domain	SH3	CACNB1 DLG5 OBSCN SHANK2 CASKIN2 TJP1 HCLS1	4.71e-04	216	119	7	SM00326
Domain	SH3	CACNB1 DLG5 OBSCN SHANK2 CASKIN2 TJP1 HCLS1	4.71e-04	216	119	7	PS50002
Domain	Laminin_G	HSPG2 COL27A1 CELSR3 USH2A	5.10e-04	58	119	4	IPR001791
Domain	SH3_domain	CACNB1 DLG5 OBSCN SHANK2 CASKIN2 TJP1 HCLS1	5.25e-04	220	119	7	IPR001452
Domain	-	EPHB3 ZCCHC14 ARAP3 SHANK2 CASKIN2	5.86e-04	106	119	5	1.10.150.50
Domain	EGF-type_Asp/Asn_hydroxyl_site	LDLR LRP8 CELSR3 DLK2 NPNT	5.86e-04	106	119	5	IPR000152
Domain	Guanylate_kin	CACNB1 DLG5 TJP1	5.89e-04	26	119	3	PF00625
Domain	GK/Ca_channel_bsu	CACNB1 DLG5 TJP1	5.89e-04	26	119	3	IPR008145
Domain	Guanylate_kin-like_dom	CACNB1 DLG5 TJP1	5.89e-04	26	119	3	IPR008144
Domain	GuKc	CACNB1 DLG5 TJP1	5.89e-04	26	119	3	SM00072
Domain	Nuc_rcpt_coact	NCOA3 CREBBP	5.94e-04	6	119	2	IPR009110
Domain	WxxW_domain	MUC5B MUC5AC	5.94e-04	6	119	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	5.94e-04	6	119	2	PF13330
Domain	EGF_3	HSPG2 LDLR LRP8 CELSR3 DLK2 OTOG NPNT	7.75e-04	235	119	7	PS50026
Domain	EGF_LAM_2	HSPG2 CELSR3 USH2A	9.03e-04	30	119	3	PS50027
Domain	EGF_LAM_1	HSPG2 CELSR3 USH2A	9.03e-04	30	119	3	PS01248
Domain	SAM/pointed	EPHB3 ZCCHC14 ARAP3 SHANK2 CASKIN2	9.16e-04	117	119	5	IPR013761
Domain	SAM_1	EPHB3 ZCCHC14 SHANK2 CASKIN2	9.32e-04	68	119	4	PF00536
Domain	EGF-like_dom	HSPG2 LDLR LRP8 CELSR3 DLK2 OTOG NPNT	1.09e-03	249	119	7	IPR000742
Domain	Ataxin-2_C	ATXN2L ATXN2	1.41e-03	9	119	2	IPR009818
Domain	PAM2	ATXN2L ATXN2	1.41e-03	9	119	2	PF07145
Domain	ZU5	ANK2 TJP1	1.41e-03	9	119	2	SM00218
Domain	EGF_Lam	HSPG2 CELSR3 USH2A	1.42e-03	35	119	3	SM00180
Domain	Laminin_EGF	HSPG2 CELSR3 USH2A	1.42e-03	35	119	3	PF00053
Domain	RA	MYO9A ARAP3 PLCE1	1.54e-03	36	119	3	PF00788
Domain	EGF_2	HSPG2 MUC12 LDLR LRP8 CELSR3 DLK2 NPNT	1.55e-03	265	119	7	PS01186
Domain	RA	MYO9A ARAP3 PLCE1	1.67e-03	37	119	3	PS50200
Domain	ZU5	ANK2 TJP1	1.75e-03	10	119	2	PS51145
Domain	VWFC_2	MUC19 MUC5B MUC5AC	1.81e-03	38	119	3	PS50184
Domain	VWC	MUC19 MUC5B MUC5AC	1.81e-03	38	119	3	SM00214
Domain	Laminin_EGF	HSPG2 CELSR3 USH2A	1.81e-03	38	119	3	IPR002049
Domain	LDLR_class-A_CS	HSPG2 LDLR LRP8	2.10e-03	40	119	3	IPR023415
Domain	RA_dom	MYO9A ARAP3 PLCE1	2.10e-03	40	119	3	IPR000159
Domain	Laminin_G_2	HSPG2 CELSR3 USH2A	2.10e-03	40	119	3	PF02210
Domain	FYVE_2	SYTL5 RIMS1	2.13e-03	11	119	2	PF02318
Domain	SAM	EPHB3 ARAP3 SHANK2 CASKIN2	2.42e-03	88	119	4	SM00454
Domain	RABBD	SYTL5 RIMS1	2.55e-03	12	119	2	PS50916
Domain	ZU5	ANK2 TJP1	2.55e-03	12	119	2	PF00791
Domain	ZU5_dom	ANK2 TJP1	2.55e-03	12	119	2	IPR000906
Domain	Rab_BD	SYTL5 RIMS1	2.55e-03	12	119	2	IPR010911
Domain	PDZ	DLG5 GORASP2 SHANK2 TJP1 RIMS1	2.59e-03	148	119	5	SM00228
Domain	-	DLG5 GORASP2 SHANK2 TJP1 RIMS1	2.74e-03	150	119	5	2.30.42.10
Domain	LamG	HSPG2 CELSR3 USH2A	2.76e-03	44	119	3	SM00282
Domain	PDZ	DLG5 GORASP2 SHANK2 TJP1 RIMS1	2.82e-03	151	119	5	PS50106
Domain	PDZ	DLG5 GORASP2 SHANK2 TJP1 RIMS1	2.90e-03	152	119	5	IPR001478
Domain	SAM_DOMAIN	EPHB3 ARAP3 SHANK2 CASKIN2	3.19e-03	95	119	4	PS50105
Domain	Growth_fac_rcpt_	EPHB3 HSPG2 LDLR LRP8 NPNT	3.24e-03	156	119	5	IPR009030
Domain	EGF_Ca-bd_CS	LDLR LRP8 DLK2 NPNT	3.44e-03	97	119	4	IPR018097
Domain	SEA	HSPG2 MUC16	3.48e-03	14	119	2	SM00200
Domain	Ldl_recept_b	LDLR LRP8	3.48e-03	14	119	2	PF00058
Domain	LDLRB	LDLR LRP8	3.48e-03	14	119	2	PS51120
Domain	EGF_CA	LDLR LRP8 DLK2 NPNT	3.70e-03	99	119	4	PS01187
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUC5AC MUC6	3.50e-08	16	88	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUC5AC MUC6	4.93e-08	17	88	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5B MUC5AC MUC6	1.59e-07	21	88	5	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUC5AC MUC6	2.60e-07	23	88	5	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 MUC5AC MUC6	5.01e-07	26	88	5	M27483
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	HSPG2 CHSY1 MUC16 MUC5B MUC12 ADAMTS12 MUC5AC MUC6	2.99e-06	143	88	8	M27275
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 ADAMTS12 MUC5AC MUC6	4.00e-06	68	88	6	M27303
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC5B MUC12 CREBBP PAK1 MUC5AC MUC6	2.66e-05	140	88	7	M27484
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC19 MUC16 MUC5B MUC5AC MUC6	3.52e-05	60	88	5	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC12 MUC5AC MUC6	4.13e-05	62	88	5	M546
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC19 MUC16 MUC5B ADAMTS12 MUC5AC MUC6	6.03e-05	109	88	6	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC12 ADAMTS12 MUC5AC MUC6	6.67e-05	111	88	6	M27416
Pathway	REACTOME_DISEASES_OF_METABOLISM	HSPG2 CHSY1 MUC16 MUC5B MUC12 ADAMTS12 MUC5AC MUC6	1.66e-04	250	88	8	M27554
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	GATAD2A EP400 KAT2A KDM6B CREBBP JAK2 TAF9 SAP130	2.94e-04	272	88	8	M29619
Pathway	WP_EGFEGFR_SIGNALING	NCOA3 JAK2 ATXN2 PAK1 DNM1 PLCE1	5.23e-04	162	88	6	M39334
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MYO9A OBSCN LARP1 PATL1 ARHGAP35 HM13 CREBBP CASZ1 LRP8 PCNX2 JAK2 TSC22D1 SHANK2 INTS2 ATXN2 TJP1 SUPT6H SETBP1 ANKRD11 CAMKMT XYLB RIMS1 MBD5 ZNF839 WDR13 CFAP69 SAP130 CLBA1	2.30e-13	1489	122	28	28611215
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 EP400 OBSCN CHSY1 KAT2A ARHGAP35 KDM6B SRCAP WNK1 LDLR CIC CASZ1 PCNX2 JAK2 ZCCHC14 GAS2L1 ARAP3 SHANK2 CELSR3 ANKRD11 WDR90 SYVN1 MBD5 ZNF839	7.62e-13	1105	122	24	35748872
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B MUC5AC MUC6	2.93e-12	6	122	5	19110483
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12 MUC5AC MUC6	2.95e-11	18	122	6	18834073
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L DLG5 EP400 MYO9A RBM33 SRCAP WNK1 CREBBP CIC EMSY SUPT6H BSN TAF9 ZMYM6 VCPIP1	2.58e-09	588	122	15	38580884
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	EP400 TSG101 TSC22D2 MAGEE1 WNK1 CIC ZNF469 ATXN2 SETBP1 PAK1 WDR90 BSN SAP130	4.27e-09	430	122	13	35044719
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DLG5 EP400 LARP1 CHSY1 KDM6B CELSR3 GTF3C2 INTS2 CASKIN2 SUPT6H SETBP1 ROBO2 WDR90 BSN	5.70e-09	529	122	14	14621295
Pubmed	O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.	EMSY SHANK2 CTNND2 BSN	1.40e-07	14	122	4	16452088
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC MUC6	1.68e-07	4	122	3	23807779
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC MUC6	1.68e-07	4	122	3	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC MUC6	1.68e-07	4	122	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC MUC6	1.68e-07	4	122	3	29869461
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC5AC MUC6	1.68e-07	4	122	3	12676567
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ATXN2L HSPG2 CACNB1 MAGEE1 RUNX1T1 WNK1 CIC GORASP2 ATXN2 ROBO2 SYVN1 TAF9 HCLS1	2.42e-07	608	122	13	16713569
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	MYO9A COL27A1 SPECC1 RIMS1 BSN DNM1 OTOG VCPIP1	7.68e-07	208	122	8	33230847
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ATXN2L NCOA3 RBM33 CREBBP CIC TAF9 SPTY2D1	1.17e-06	152	122	7	38360978
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DLG5 EP400 RBM33 PPP1R12B KAT2A SPECC1 CIC CASZ1 EMSY GORASP2 SHANK2 GTF3C2 INTS2 ATXN2 SUPT6H ANKRD11 CTNND2 TAF9 SPTY2D1	1.19e-06	1497	122	19	31527615
Pubmed	A human MAP kinase interactome.	MYO9A RBM33 MUC12 WNK1 CREBBP CIC TSC22D1 PAK1 MBD5 ZNF839 TNS1	1.23e-06	486	122	11	20936779
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	GATAD2A EP400 KAT2A KDM6B SRCAP CREBBP ANKRD11	1.45e-06	157	122	7	30186101
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L DLG5 PLK2 MYO9A LARP1 WNK1 SPECC1 CIC ZCCHC14 CASKIN2 TJP1 ANKRD11 OTOG VCPIP1	2.11e-06	861	122	14	36931259
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	EP400 COL27A1 FNDC1 ZNF469 SYVN1 VCPIP1	2.23e-06	107	122	6	11347906
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PLK2 FN1 ANK2 TSG101 KDM6B SPECC1 CREBBP GORASP2 CELSR3 TJP1 PAK1 CTNND2 DNM1 WDR13 MTUS2 VCPIP1 B4GALT3	2.65e-06	1285	122	17	35914814
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATXN2L FN1 ANK2 MYO9A PPP1R12B LARP1 TSG101 ARHGAP35 SPECC1 GAS2L1 SHANK2 TJP1 RIMS1 CTNND2 BSN DNM1 TNS1 MTUS2	2.66e-06	1431	122	18	37142655
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L EP400 LARP1 ARHGAP35 SRCAP CREBBP EMSY GTF3C2 TJP1 SAP130 VCPIP1	3.97e-06	549	122	11	38280479
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATXN2L CACNB1 ANK2 SPECC1 SHANK2 PAK1 RIMS1 CTNND2 BSN	4.01e-06	347	122	9	17114649
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA3 EP400 RBM33 CREBBP CIC CASZ1 EMSY SAP130	5.05e-06	268	122	8	33640491
Pubmed	Large-scale concatenation cDNA sequencing.	ATXN2L TGIF2 ANK2 RUNX1T1 SHANK2 GTF3C2 TJP1 SUPT6H CTNND2 DNM1 CLBA1	5.48e-06	568	122	11	9110174
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	ATXN2L FN1 LARP1 CHSY1 PATL1 KAT2A HM13 WNK1 GTF3C2 ATXN2	5.69e-06	462	122	10	31138677
Pubmed	A "double adaptor" method for improved shotgun library construction.	ATXN2L TGIF2 ANK2 RUNX1T1 SHANK2 GTF3C2 TJP1 SUPT6H CTNND2 DNM1 CLBA1	6.05e-06	574	122	11	8619474
Pubmed	c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation.	KAT2A TAF9 SAP130	6.81e-06	11	122	3	12660246
Pubmed	Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.	CHSY1 POU2AF1 ZNF469 TJP1	6.94e-06	35	122	4	23291589
Pubmed	A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.	EP400 KAT2A SRCAP TAF9	6.94e-06	35	122	4	20946988
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA3 CACNB1 ANK2 EMSY SHANK2 ATXN2 TJP1 PAK1 DCHS1 RIMS1 CTNND2 BSN DNM1 TNS1	7.60e-06	963	122	14	28671696
Pubmed	Deficiency in Crumbs homolog 2 (Crb2) affects gastrulation and results in embryonic lethality in mice.	HSPG2 FN1 TJP1	9.05e-06	12	122	3	22072575
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	1.22e-05	2	122	2	7513696
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	1.22e-05	2	122	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	1.22e-05	2	122	2	14988081
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	1.22e-05	2	122	2	15563276
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	1.22e-05	2	122	2	17621824
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	1.22e-05	2	122	2	22220206
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	1.22e-05	2	122	2	24317696
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	1.22e-05	2	122	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	1.22e-05	2	122	2	35776514
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	1.22e-05	2	122	2	24327612
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	1.22e-05	2	122	2	28321513
Pubmed	Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.	HSPG2 MUC5AC	1.22e-05	2	122	2	23836919
Pubmed	Mucin 16 Promotes Colorectal Cancer Development and Progression Through Activation of Janus Kinase 2.	MUC16 JAK2	1.22e-05	2	122	2	33982216
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	1.22e-05	2	122	2	28607090
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	1.22e-05	2	122	2	31030254
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	1.22e-05	2	122	2	23527003
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	1.22e-05	2	122	2	16540890
Pubmed	Differential deposition of basement membrane components during formation of the caudal neural tube in the mouse embryo.	HSPG2 FN1	1.22e-05	2	122	2	3665768
Pubmed	The catalytic subunit of the SWR1 remodeler is a histone chaperone for the H2A.Z-H2B dimer.	EP400 SRCAP	1.22e-05	2	122	2	24507717
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	1.22e-05	2	122	2	27845589
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	1.22e-05	2	122	2	27435107
Pubmed	Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib.	CSF3R SETBP1	1.22e-05	2	122	2	28209656
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	1.22e-05	2	122	2	26871672
Pubmed	Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome.	SRCAP CREBBP	1.22e-05	2	122	2	22265015
Pubmed	Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.	ATXN2L ATXN2	1.22e-05	2	122	2	8896555
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	1.22e-05	2	122	2	11988092
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	1.22e-05	2	122	2	11587997
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	1.22e-05	2	122	2	24722639
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5B MUC5AC	1.22e-05	2	122	2	34656442
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	1.22e-05	2	122	2	34058148
Pubmed	Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.	MUC16 JAK2	1.22e-05	2	122	2	25691062
Pubmed	Quantifying Protection in Disordered Proteins Using Millisecond Hydrogen Exchange-Mass Spectrometry and Peptic Reference Peptides.	NCOA3 CREBBP	1.22e-05	2	122	2	28675294
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	1.22e-05	2	122	2	18782111
Pubmed	C-Mannosylation of MUC5AC and MUC5B Cys subdomains.	MUC5B MUC5AC	1.22e-05	2	122	2	14718370
Pubmed	MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.	MUC16 JAK2	1.22e-05	2	122	2	21785467
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5B MUC5AC	1.22e-05	2	122	2	21653907
Pubmed	Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs.	MUC5AC MUC6	1.22e-05	2	122	2	9422745
Pubmed	MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.	MUC5B MUC5AC	1.22e-05	2	122	2	36427316
Pubmed	Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice.	LDLR JAK2	1.22e-05	2	122	2	30571460
Pubmed	Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.	NCOA3 ANKRD11	1.22e-05	2	122	2	31788936
Pubmed	Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.	MUC5AC MUC6	1.22e-05	2	122	2	12360467
Pubmed	Mucin deficiency causes functional and structural changes of the ocular surface.	MUC5B MUC5AC	1.22e-05	2	122	2	23272068
Pubmed	Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.	MUC5B MUC5AC	1.22e-05	2	122	2	27729120
Pubmed	Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer.	NCOA3 KAT2A	1.22e-05	2	122	2	32987137
Pubmed	De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.	MUC5B MUC5AC	1.22e-05	2	122	2	36111525
Pubmed	Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin.	NCOA3 CREBBP	1.22e-05	2	122	2	21632823
Pubmed	A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse.	LDLR LRP8	1.22e-05	2	122	2	8662771
Pubmed	Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin.	MUC5B MUC5AC	1.22e-05	2	122	2	32348677
Pubmed	Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.	MUC5B MUC5AC	1.22e-05	2	122	2	24332705
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	GATAD2A EP400 KAT2A SRCAP LDLR CIC CASZ1 EMSY GTF3C2 INTS2 SUPT6H ANKRD11 TAF9 SAP130 SPTY2D1 VCPIP1	1.24e-05	1294	122	16	30804502
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	GATAD2A EP400 EMSY SUPT6H TAF9 SAP130	1.34e-05	146	122	6	23892456
Pubmed	Deletion of astroglial connexins weakens the blood-brain barrier.	HSPG2 FN1 TJP1	1.49e-05	14	122	3	22472609
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	DBF4B OBSCN LARP1 ARHGAP35 TJP1 PPP1R37 HCLS1	1.59e-05	226	122	7	31452512
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	CACNB1 ARHGAP35 SHANK2 RIMS1 CTNND2 BSN VCPIP1	1.82e-05	231	122	7	16452087
Pubmed	Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice.	HSPG2 FN1 TJP1	2.28e-05	16	122	3	11564885
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	ATXN2L GATAD2A ANK2 ATXN2 DCHS1	2.96e-05	101	122	5	26949739
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ATXN2L DLG5 LARP1 SPECC1 GORASP2 SHANK2 CASKIN2 TJP1 PPP1R37 VCPIP1	3.20e-05	565	122	10	25468996
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KDM6B SRCAP WNK1 CIC RIMS1	3.41e-05	104	122	5	9205841
Pubmed	Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.	MUC16 MUC5AC	3.65e-05	3	122	2	33232357
Pubmed	Ataxin-2-like is a regulator of stress granules and processing bodies.	ATXN2L ATXN2	3.65e-05	3	122	2	23209657
Pubmed	MBD5 regulates iron metabolism via methylation-independent genomic targeting of Fth1 through KAT2A in mice.	KAT2A MBD5	3.65e-05	3	122	2	24750026
Pubmed	High-Mobility Group Box 1 Upregulates MUC5AC and MUC5B Expression in Primary Airway Epithelial Cells.	MUC5B MUC5AC	3.65e-05	3	122	2	29286856
Pubmed	Nebulized Menthol Impairs Mucociliary Clearance via TRPM8 and MUC5AC/MUC5B in Primary Airway Epithelial Cells.	MUC5B MUC5AC	3.65e-05	3	122	2	36675209
Pubmed	Regulation of HER2 oncogene transcription by a multifunctional coactivator/corepressor complex.	NCOA3 ANKRD11	3.65e-05	3	122	2	24678732
Pubmed	Mode of interaction between beta2GPI and lipoprotein receptors suggests mutually exclusive binding of beta2GPI to the receptors and anionic phospholipids.	LDLR LRP8	3.65e-05	3	122	2	20223219
Pubmed	Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps.	MUC5B MUC5AC	3.65e-05	3	122	2	29802623
Interaction	TOP3B interactions	HSPG2 EP400 RBM33 OBSCN CHSY1 PATL1 KAT2A ARHGAP35 KDM6B SRCAP WNK1 LDLR CIC CASZ1 PCNX2 JAK2 ZCCHC14 GAS2L1 GORASP2 ARAP3 SHANK2 CELSR3 ATXN2 ANKRD11 WDR90 SYVN1 MBD5 ZNF839	2.81e-08	1470	120	28	int:TOP3B
Interaction	HNF4A interactions	NCOA3 EP400 MUC19 KAT2A SRCAP CREBBP CIC EMSY GTF3C2 TAF9 SAP130	7.80e-07	275	120	11	int:HNF4A
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC5B MUC12 MUC5AC MUC6	8.02e-10	21	93	6	648
GeneFamily	Fibronectin type III domain containing	EPHB3 FN1 OBSCN FNDC1 CSF3R ROBO2 LRRN4 USH2A	1.70e-06	160	93	8	555
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA3 KAT2A CREBBP	8.50e-05	17	93	3	486
GeneFamily	Sterile alpha motif domain containing	EPHB3 ZCCHC14 ARAP3 SHANK2 CASKIN2	9.04e-05	88	93	5	760
GeneFamily	Ankyrin repeat domain containing	ANK2 PPP1R12B SOWAHA ARAP3 SHANK2 CASKIN2 ANKRD11	2.52e-04	242	93	7	403
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOA3 EP400 ATXN2	2.79e-04	25	93	3	775
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	CACNB1 DLG5 TJP1	3.14e-04	26	93	3	904
GeneFamily	PDZ domain containing	DLG5 GORASP2 SHANK2 TJP1 RIMS1	1.13e-03	152	93	5	1220
GeneFamily	Low density lipoprotein receptors	LDLR LRP8	1.97e-03	13	93	2	634
GeneFamily	Beta 4-glycosyltransferases	CHSY1 B4GALT3	3.39e-03	17	93	2	425
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	COL27A1 LARP1 CREBBP SHANK2 ANKRD11 ROBO2 MAP3K13 DNM1 WDR13 TNS1 RNF212B	4.18e-06	417	122	11	M39224
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	ANK2 MUC19 RUNX1T1 CASZ1 SHANK2 CELSR3 ROBO2 RIMS1 BSN USH2A MTUS2	1.17e-05	465	122	11	M39066
Coexpression	NAGY_STAGA_COMPONENTS_HUMAN	KAT2A TAF9 SAP130	2.72e-05	13	122	3	M10514
Coexpression	GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	TGIF2 KDM6B ARMCX2 JAK2 TSC22D1 INTS2 ATXN2	4.06e-05	198	122	7	M9163
Coexpression	GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP	FN1 TSG101 MAGEE1 ARHGAP35 ATXN2 SYVN1 CLBA1	4.33e-05	200	122	7	M3850
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ANK2 RBM33 MUC19 ARHGAP35 RUNX1T1 CASZ1 SHANK2 CELSR3 ROBO2 RIMS1 CTNND2 BSN DNM1 MTUS2 NPNT ARMH4	5.59e-05	1106	122	16	M39071
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TJP1 ANKRD11 ROBO2 MBD5 NPNT PLCE1 ARMH4	6.26e-05	212	122	7	M39221
Coexpression	GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN	PLK2 TNFRSF10B KDM6B WNK1 ZCCHC14 NPNT	7.17e-05	149	122	6	M6708
Coexpression	NAGY_TFTC_COMPONENTS_HUMAN	KAT2A TAF9 SAP130	7.63e-05	18	122	3	M2974
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK2 PPP1R12B OBSCN CASZ1 TSC22D1 ROBO2 CTNND2 PLCE1	5.13e-08	188	122	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSC22D1 SHANK2 SETBP1 PAK1 ROBO2 RIMS1 DNM1 MTUS2	7.66e-08	198	122	8	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	CHSY1 POU2AF1 FNDC1 ZNF469 SOWAHA BSN ARMH4	3.54e-07	164	122	7	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PLK2 ANK2 TMPRSS13 PPP1R12B RUNX1T1 SOWAHA MTUS2	5.49e-07	175	122	7	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 MUC16 MUC5B LDLR CASZ1 RIMS1 MUC5AC	6.39e-07	179	122	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PPP1R12B RUNX1T1 SPECC1 TMEM200B TNS1 PLCE1	7.41e-07	183	122	7	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FN1 RUNX1T1 ADAMTS12 SETBP1 ROBO2 NPNT PLCE1	1.10e-06	194	122	7	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB3 FN1 RUNX1T1 FNDC1 RAB34 SETBP1 ROBO2	1.17e-06	196	122	7	cbfe01ba8071864e19b37028236ae35789f630fe
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	FN1 COL27A1 RUNX1T1 ADAMTS12 SETBP1 ROBO2 CFAP69	1.21e-06	197	122	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	FN1 ANK2 COL27A1 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.26e-06	198	122	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSC22D1 SHANK2 SETBP1 ROBO2 RIMS1 DNM1 MTUS2	1.26e-06	198	122	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9A LDLR SHANK2 CSF3R LAMP3 MAP3K13 NPNT	1.30e-06	199	122	7	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9A LDLR SHANK2 CSF3R LAMP3 MAP3K13 NPNT	1.30e-06	199	122	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB3 PLK2 MUC16 MUC5B CASZ1 SHANK2 RIMS1	1.34e-06	200	122	7	85c0f038bcfb42669dca2b80273b0f8a1421405e
ToppCell	NS-critical-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK2 TMPRSS13 PPP1R12B MUC19 RUNX1T1 MTUS2	7.00e-06	168	122	6	6a233045638cb83dab64789b996b7598c325001e
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNB1 LRP8 SHANK2 WDR90 LRRN4 SAP130	7.00e-06	168	122	6	a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCell	NS-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC12 TMEM200B WDR90 CFAP69 CLBA1 PLCE1	7.49e-06	170	122	6	f6a0162bb690dbc19ff1cec64cb933744ad3b496
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CHSY1 LRP8 TSC22D1 CAMKMT CTNND2	8.01e-06	172	122	6	24ecfda5e43e28f190089770cd2eae5bf2ed292b
ToppCell	facs-Marrow-KLS-18m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A JAK2 RAB34 PAK1 CTNND2 PLCE1	8.01e-06	172	122	6	979fd7b435f59b8a4d290a809cf76147d4c63d48
ToppCell	droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CHSY1 LRP8 TSC22D1 CAMKMT CTNND2	8.01e-06	172	122	6	db5a31cafce4346fe459d7f35210823fd7004439
ToppCell	facs-Marrow-KLS-18m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A JAK2 RAB34 PAK1 CTNND2 PLCE1	8.01e-06	172	122	6	f4d7f416802218ce56408fa4cb8a555d846bc85b
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	SHANK2 TJP1 CTNND2 TNS1 NPNT PLCE1	8.56e-06	174	122	6	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	POU2AF1 IGLV3-25 GORASP2 SETBP1 SYVN1 B4GALT3	9.74e-06	178	122	6	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NCOA3 POU2AF1 IGLV3-25 IGLV3-21 IGLV3-10 SPACA3	1.04e-05	180	122	6	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TJP1 PAK1 ROBO2 NPNT PLCE1 ARMH4	1.07e-05	181	122	6	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TJP1 PAK1 ROBO2 NPNT PLCE1 ARMH4	1.07e-05	181	122	6	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 POU2AF1 MUC5B SHANK2 RIMS1 MUC5AC	1.11e-05	182	122	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LDLR SHANK2 CSF3R LAMP3 MAP3K13 NPNT	1.14e-05	183	122	6	6847c1252d6bb105524f812658112517fd351eab
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	COL27A1 ADAMTS12 FNDC1 ZNF469 ROBO2 ARMH4	1.18e-05	184	122	6	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHANK2 TJP1 CTNND2 TNS1 NPNT PLCE1	1.18e-05	184	122	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL27A1 SPECC1 ADAMTS12 SETBP1 RIMS1 PLCE1	1.18e-05	184	122	6	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPHB3 HSPG2 FNDC1 RAB34 INTS2 ARMH4	1.18e-05	184	122	6	d754c3de621429b220ae4ac426cdfc619e848462
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHANK2 TJP1 CTNND2 TNS1 NPNT PLCE1	1.18e-05	184	122	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNFRSF10B HM13 LDLR LRP8 CSF3R LAMP3	1.25e-05	186	122	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	FN1 COL27A1 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.29e-05	187	122	6	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	LDLR CASZ1 SHANK2 LAMP3 MAP3K13 NPNT	1.33e-05	188	122	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	NCOA3 TGIF2 ADAMTS12 ZCCHC14 FNDC1 ZNF469	1.33e-05	188	122	6	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	FN1 RUNX1T1 RAB34 ROBO2 TNS1 NPNT	1.33e-05	188	122	6	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL27A1 SRCAP LDLR SETBP1 DCHS1 ZNF839	1.37e-05	189	122	6	bccb3481ffed597c845fe860da658505316105b5
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLK2 TMPRSS13 KDM6B LDLR TSC22D1 DLK2	1.37e-05	189	122	6	1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FN1 COL27A1 RUNX1T1 TSC22D1 ROBO2 TNS1	1.37e-05	189	122	6	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC12 TMEM200B WDR90 CFAP69 CLBA1 PLCE1	1.41e-05	190	122	6	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	FN1 ANK2 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.41e-05	190	122	6	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	POU2AF1 HM13 IGLV3-25 IGLV3-21 IGLV3-10 HCLS1	1.45e-05	191	122	6	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LDLR SHANK2 CSF3R LAMP3 MAP3K13 NPNT	1.45e-05	191	122	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	ANK2 PPP1R12B OBSCN CASZ1 CTNND2 MTUS2	1.45e-05	191	122	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 RUNX1T1 ADAMTS12 SETBP1 ROBO2 NPNT	1.45e-05	191	122	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FN1 RUNX1T1 ADAMTS12 SETBP1 ROBO2 NPNT	1.54e-05	193	122	6	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	HSPG2 FN1 CHSY1 TNFRSF10B ARAP3 SETBP1	1.54e-05	193	122	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	POU2AF1 HM13 IGLV3-21 SYVN1 SPACA3 B4GALT3	1.54e-05	193	122	6	1f50823bd7ef00500d9d81f0f5c2f6c940c4b1a6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 SPECC1 ARAP3 CTNND2	1.54e-05	193	122	6	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	POU2AF1 HM13 IGLV3-21 SYVN1 SPACA3 B4GALT3	1.54e-05	193	122	6	b9c00df1b216eaa4283315713f1c9ef552d3d435
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	FN1 ANK2 RUNX1T1 ADAMTS12 FNDC1 ROBO2	1.59e-05	194	122	6	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FN1 RUNX1T1 ADAMTS12 SETBP1 ROBO2 NPNT	1.59e-05	194	122	6	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LDLR CASZ1 SHANK2 CSF3R LAMP3 NPNT	1.59e-05	194	122	6	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	ANK2 PPP1R12B OBSCN CASZ1 CTNND2 MTUS2	1.63e-05	195	122	6	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 TJP1 LRRN4 CTNND2 TNS1 NPNT	1.63e-05	195	122	6	07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK2 COL27A1 TSC22D1 FNDC1 ROBO2 RIMS1	1.63e-05	195	122	6	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	ANK2 PPP1R12B OBSCN CASZ1 CTNND2 MTUS2	1.63e-05	195	122	6	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	E17.5-Mesenchymal-myocytic_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK2 COL27A1 TSC22D1 FNDC1 ROBO2 RIMS1	1.63e-05	195	122	6	01a750d660993017af00736215cbcff2de5909c1
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 TJP1 LRRN4 CTNND2 TNS1 NPNT	1.63e-05	195	122	6	b65511770ed67f7447847e2187555b362988af45
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B CASZ1 SHANK2 RIMS1 MUC5AC	1.63e-05	195	122	6	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	P03-Mesenchymal\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FN1 COL27A1 RAB34 ROBO2 TNS1 NPNT	1.63e-05	195	122	6	6180309c6ae278b996fd98c57461cbc129c028ba
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PLK2 FN1 COL27A1 FNDC1 ARMH4	1.63e-05	195	122	6	095b8e0be385b6390420589124a95fa4ba3682ab
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP1R12B TMEM200B RAB34 RIMS1 TNS1 NPNT	1.63e-05	195	122	6	6524ee7bdc70bb5955dd6a6f134a8e6d8b5f2b39
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FN1 COL27A1 FNDC1 ROBO2 TNS1 NPNT	1.68e-05	196	122	6	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-myocytic\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PPP1R12B TMEM200B RAB34 RIMS1 TNS1 NPNT	1.68e-05	196	122	6	20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FN1 ANK2 ADAMTS12 SETBP1 ROBO2 NPNT	1.73e-05	197	122	6	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSC22D1 SHANK2 SETBP1 RIMS1 DNM1 MTUS2	1.78e-05	198	122	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSC22D1 SHANK2 SETBP1 RIMS1 DNM1 MTUS2	1.78e-05	198	122	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TSC22D1 SETBP1 PAK1 RIMS1 DNM1 MTUS2	1.78e-05	198	122	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	FN1 ANK2 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.78e-05	198	122	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Caecum-(2)_B_cell-(21)_B_cell_IgG_Plasma\|Caecum / shred on region, Cell_type, and subtype	NCOA3 POU2AF1 HM13 IGLV3-21 TJP1 MUC6	1.78e-05	198	122	6	3893fcfc1de5937be3ccc7e545f711f2c95a2827
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PLK2 MUC16 POU2AF1 MUC5B SHANK2 RIMS1	1.78e-05	198	122	6	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	Caecum-B_cell-B_cell_IgG_Plasma\|Caecum / Region, Cell class and subclass	NCOA3 POU2AF1 HM13 IGLV3-21 TJP1 MUC6	1.78e-05	198	122	6	d8cb78b1763710a158cf22b59aebaa44afd2374c
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LDLR SHANK2 CSF3R LAMP3 MAP3K13 NPNT	1.83e-05	199	122	6	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FCHO2 SHANK2 CSF3R LAMP3 MAP3K13 NPNT	1.83e-05	199	122	6	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.83e-05	199	122	6	8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.83e-05	199	122	6	da5a88749d859d535daa030d0974485906cc0ba7
ToppCell	ASK428-Epithelial\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	LDLR TSC22D1 CSF3R LAMP3 TNS1 NPNT	1.83e-05	199	122	6	ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO9A FCHO2 LDLR CSF3R LAMP3 NPNT	1.83e-05	199	122	6	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	EPHB3 MYO9A LDLR SHANK2 SYTL5 NPNT	1.89e-05	200	122	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 ANK2 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.89e-05	200	122	6	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.89e-05	200	122	6	b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B LDLR CASZ1 SHANK2 MAP3K13	1.89e-05	200	122	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PPP1R12B ADAMTS12 FNDC1 RAB34 ROBO2 RIMS1	1.89e-05	200	122	6	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MUC16 CASZ1 TSC22D1 TJP1 LAMP3 MAP3K13	1.89e-05	200	122	6	1c02a7f4047d1d2208cc522c6bb4a4989d7845bb
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.89e-05	200	122	6	dba96cda5f3b780a3d4171b61bc8aaddc1f5d466
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.89e-05	200	122	6	2e47888e041ec3d265425d1df97b6665c6da889c
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 ANK2 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.89e-05	200	122	6	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 ANK2 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.89e-05	200	122	6	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.89e-05	200	122	6	50fa0f8a3e490d5941b34e66a10158eba6c909d4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 ANK2 RUNX1T1 ADAMTS12 SETBP1 ROBO2	1.89e-05	200	122	6	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.89e-05	200	122	6	ced14d83222dbebca85c40540e76824e683354f3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 FN1 RUNX1T1 ARAP3 CASKIN2 DCHS1	1.89e-05	200	122	6	7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MUC16 CASZ1 TSC22D1 TJP1 LAMP3 MAP3K13	1.89e-05	200	122	6	03051d2190244208905e1611019d4b8fd200bae0
ToppCell	Control-Endothelial-Endothelial-Activated_Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLK2 CHSY1 TNFRSF10B TSC22D2 DLK2	2.09e-05	121	122	5	a5962d1c476e6966870832b72d511607e047248b
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	DBF4B KAT2A ARHGAP35 DNM1 B4GALT3	3.06e-05	131	122	5	88b3298110bc2333ffa202a3f41ac0d24e2308c7
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NCOA3 PPP1R12B KDM6B ATXN2 ANKRD11	3.53e-05	135	122	5	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PLK2 SPECC1 SHANK2 PAK1 CLBA1	4.06e-05	139	122	5	4f4b447e85dda69058d9edbcfe37e55751dd90a6
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	EPHB3 MUC5B ARHGAP35 KDM6B SRCAP EMSY GAS2L1 ATXN2 SETBP1 TNS1	8.92e-08	194	121	10	4529_DN
Drug	Scopoletin [92-61-5]; Up 200; 20.8uM; HL60; HT_HG-U133A	HSPG2 CACNB1 FN1 ARMCX2 CASZ1 ADAMTS12 TJP1 CAMKMT CTNND2 CFAP69	1.19e-07	200	121	10	3131_UP
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	ARHGAP35 ARMCX2 ADAMTS12 PCNX2 CASKIN2 CAMKMT CTNND2 CFAP69 TNS1	1.06e-06	196	121	9	3724_DN
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	FN1 PPP1R12B KDM6B CASZ1 PCNX2 CASKIN2 ZNF839 ZMYM6 VCPIP1	1.11e-06	197	121	9	7230_DN
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; HL60; HT_HG-U133A	CACNB1 DLG5 ANK2 TNFRSF10B SRCAP CASZ1 ZNF839 PIGO VCPIP1	1.21e-06	199	121	9	2408_DN
Drug	troglitazone; Down 200; 10uM; PC3; HG-U133A	PLK2 LDLR PCNX2 ARAP3 ATXN2 SUPT6H TNS1 CLBA1	9.16e-06	193	121	8	431_DN
Drug	Graveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A	TSC22D2 ARHGAP35 CASZ1 ZCCHC14 RIMS1 MAP3K13 CTNND2 MUC5AC	9.16e-06	193	121	8	4276_UP
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A	PLK2 FN1 PCNX2 ATXN2 CASKIN2 CAMKMT XYLB TNS1	9.88e-06	195	121	8	4495_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	ATXN2L DBF4B PPP1R12B SRCAP CASKIN2 DLK2 XYLB CFAP69	1.03e-05	196	121	8	4276_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HT_HG-U133A	EPHB3 FN1 ARHGAP35 WNK1 GAS2L1 CAMKMT CTNND2 CLBA1	1.06e-05	197	121	8	6683_UP
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; HL60; HT_HG-U133A	NCOA3 CACNB1 SRCAP EMSY JAK2 CELSR3 ZMYM6 VCPIP1	1.06e-05	197	121	8	2479_DN
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A	CACNB1 FN1 TSC22D2 RUNX1T1 SRCAP RIMS1 CFAP69 LILRA4	1.10e-05	198	121	8	4158_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CACNB1 TNFRSF10B TSC22D2 ARHGAP35 KDM6B CREBBP CASKIN2 MUC6	1.14e-05	199	121	8	7172_UP
Drug	Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ATXN2L FN1 MUC5B RUNX1T1 SETBP1 TNS1 HCLS1 CLBA1	1.19e-05	200	121	8	6029_UP
Drug	AC1NDT8A	PLK2 FN1 SHANK2 TNS1	4.38e-05	37	121	4	CID004631218
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	TGIF2 TNFRSF10B SRCAP WNK1 LRP8 JAK2 DNM1	5.45e-05	182	121	7	1663_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	CACNB1 TNFRSF10B ARHGAP35 LDLR CASZ1 EMSY ANKRD11	6.47e-05	187	121	7	1662_UP
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	ATXN2L TGIF2 FN1 ANK2 LARP1 ZNF839 TNS1	6.69e-05	188	121	7	6186_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A	FN1 DBF4B TNFRSF10B JAK2 CELSR3 DLK2 TNS1	7.89e-05	193	121	7	4443_DN
Drug	Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	EPHB3 ATXN2L TNFRSF10B CIC JAK2 SUPT6H CTNND2	8.15e-05	194	121	7	7457_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	EP400 KAT2A LDLR CIC CELSR3 CASKIN2 DNM1	8.15e-05	194	121	7	1060_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A	NCOA3 DBF4B MUC5B TNFRSF10B DLK2 ZNF839 CLBA1	8.15e-05	194	121	7	3689_DN
Drug	paclitaxel; Down 200; 0.1uM; MCF7; HG-U133A	LARP1 LDLR PCNX2 PPP1R37 ZNF839 TNS1 PIGO	8.15e-05	194	121	7	640_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A	ATXN2L FN1 DBF4B JAK2 ATXN2 CAMKMT TNS1	8.15e-05	194	121	7	3807_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; MCF7; HT_HG-U133A	FN1 MUC5B CIC EMSY DLK2 MUC6 CLBA1	8.15e-05	194	121	7	4417_DN
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; HL60; HG-U133A	CACNB1 TGIF2 RUNX1T1 TSC22D1 ARAP3 ATXN2 ZNF839	8.15e-05	194	121	7	1581_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	CACNB1 RUNX1T1 ZCCHC14 XYLB CFAP69 MUC5AC CLBA1	8.15e-05	194	121	7	5954_UP
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A	ATXN2L HSPG2 DBF4B TSC22D2 KDM6B SRCAP CIC	8.15e-05	194	121	7	3384_DN
Drug	Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	TNFRSF10B ARHGAP35 KDM6B LDLR CAMKMT CFAP69 TNS1	8.15e-05	194	121	7	4642_UP
Drug	Capsaicin [404-86-4]; Down 200; 13uM; HL60; HT_HG-U133A	ATXN2L HSPG2 FN1 KDM6B JAK2 PAK1 CFAP69	8.41e-05	195	121	7	3034_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	MUC5B TNFRSF10B SHANK2 ZNF839 MUC5AC HCLS1 PLCE1	8.41e-05	195	121	7	7504_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	HSPG2 MUC5B SRCAP PCNX2 LAMP3 XYLB MUC5AC	8.41e-05	195	121	7	2875_UP
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	ATXN2L JAK2 CELSR3 GTF3C2 CASKIN2 CAMKMT CTNND2	8.69e-05	196	121	7	3716_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	DLG5 TGIF2 PPP1R12B SRCAP JAK2 ZCCHC14 PIGO	8.69e-05	196	121	7	5438_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A	NCOA3 CACNB1 DLG5 TNFRSF10B WNK1 CASKIN2 VCPIP1	8.69e-05	196	121	7	6559_UP
Drug	Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	NCOA3 TSC22D2 WNK1 LDLR CASKIN2 DLK2 XYLB	8.69e-05	196	121	7	3685_DN
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	EPHB3 ARHGAP35 CIC CASZ1 PCNX2 JAK2 CLBA1	8.97e-05	197	121	7	2849_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	TNFRSF10B ARHGAP35 SRCAP WNK1 SUPT6H ZNF839 PIGO	8.97e-05	197	121	7	1803_DN
Drug	Methantheline bromide [53-46-3]; Up 200; 9.6uM; PC3; HT_HG-U133A	ATXN2L CACNB1 ARMCX2 SRCAP JAK2 CFAP69 LILRA4	8.97e-05	197	121	7	5780_UP
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	HSPG2 FN1 TNFRSF10B PCNX2 JAK2 CASKIN2 SUPT6H	8.97e-05	197	121	7	4295_DN
Drug	haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A	FN1 DBF4B KDM6B CREBBP CIC PPP1R37 MUC6	8.97e-05	197	121	7	5563_UP
Drug	Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ZCCHC14 SUPT6H LAMP3 CAMKMT XYLB CFAP69 TNS1	8.97e-05	197	121	7	6249_UP
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	DBF4B SRCAP WNK1 EMSY JAK2 LAMP3 PPP1R37	8.97e-05	197	121	7	3364_DN
Drug	Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	KAT2A TNFRSF10B ARHGAP35 ZCCHC14 CTNND2 CFAP69 CLBA1	8.97e-05	197	121	7	3230_DN
Drug	Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A	FN1 ARHGAP35 SRCAP CREBBP SETBP1 DLK2 PPP1R37	8.97e-05	197	121	7	5403_UP
Drug	Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	HSPG2 MUC5B ARHGAP35 CASKIN2 DLK2 MUC6 CLBA1	8.97e-05	197	121	7	4405_DN
Drug	ICI 182,780; Down 200; 1uM; PC3; HG-U133A	NCOA3 DLG5 TGIF2 TNFRSF10B WNK1 ATXN2 SUPT6H	8.97e-05	197	121	7	704_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	KAT2A SRCAP EMSY JAK2 LAMP3 PPP1R37 CTNND2	8.97e-05	197	121	7	3363_DN
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	FN1 DBF4B RUNX1T1 ZCCHC14 CFAP69 TNS1 CLBA1	8.97e-05	197	121	7	4142_DN
Drug	Zaprinast [37762-06-4]; Down 200; 14.8uM; MCF7; HT_HG-U133A	ATXN2L ARHGAP35 CIC CASKIN2 CTNND2 CFAP69 VCPIP1	8.97e-05	197	121	7	3226_DN
Drug	Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	HSPG2 DLG5 FN1 TSC22D2 PCNX2 ZCCHC14 CFAP69	8.97e-05	197	121	7	3453_UP
Drug	Methylatropine nitrate [52-88-0]; Up 200; 11uM; PC3; HT_HG-U133A	NCOA3 ZCCHC14 SETBP1 CTNND2 CFAP69 TNS1 PIGO	8.97e-05	197	121	7	7253_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	ATXN2L CACNB1 ARHGAP35 SRCAP WNK1 RIMS1 CFAP69	9.26e-05	198	121	7	4816_UP
Drug	Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	FN1 TSC22D2 CIC JAK2 CASKIN2 CFAP69 ZMYM6	9.26e-05	198	121	7	7235_DN
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A	ATXN2L ANK2 PCNX2 GAS2L1 SETBP1 MUC6 PLCE1	9.26e-05	198	121	7	4695_UP
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	ATXN2L TNFRSF10B SRCAP CIC ZCCHC14 CASKIN2 LAMP3	9.26e-05	198	121	7	5583_DN
Drug	Benzthiazide [91-33-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A	HSPG2 DLG5 SETBP1 DLK2 WDR13 CLBA1 LILRA4	9.26e-05	198	121	7	4952_UP
Drug	Haloperidol [52-86-8]; Up 200; 10.6uM; PC3; HG-U133A	HSPG2 PPP1R12B TNFRSF10B LDLR ATXN2 SUPT6H TNS1	9.26e-05	198	121	7	1955_UP
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CACNB1 FN1 ANK2 PPP1R12B RUNX1T1 CREBBP DLK2	9.26e-05	198	121	7	3976_UP
Drug	Picrotoxinin [17617-45-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A	ATXN2L CACNB1 FN1 LAMP3 TNS1 MUC5AC VCPIP1	9.26e-05	198	121	7	4842_UP
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A	EPHB3 HSPG2 CACNB1 SHANK2 TJP1 SETBP1 XYLB	9.26e-05	198	121	7	2929_UP
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ARMCX2 JAK2 ZCCHC14 SHANK2 CFAP69 TNS1 CLBA1	9.26e-05	198	121	7	6800_UP
Drug	Etodolac [41340-25-4]; Up 200; 14uM; MCF7; HT_HG-U133A	MUC5B TSC22D2 ARHGAP35 EMSY PCNX2 SHANK2 DLK2	9.26e-05	198	121	7	7006_UP
Drug	Oxybenzone [131-57-7]; Up 200; 17.6uM; HL60; HT_HG-U133A	PPP1R12B CASZ1 TJP1 PPP1R37 CFAP69 TNS1 PLCE1	9.26e-05	198	121	7	3092_UP
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	CACNB1 KDM6B SRCAP CASZ1 DLK2 XYLB TNS1	9.26e-05	198	121	7	7549_UP
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A	CACNB1 DLG5 TSC22D2 SRCAP GAS2L1 CAMKMT CFAP69	9.26e-05	198	121	7	6019_UP
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A	CACNB1 SRCAP SHANK2 DLK2 PPP1R37 RIMS1 MUC5AC	9.26e-05	198	121	7	3929_UP
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	EPHB3 HSPG2 ARHGAP35 SRCAP CREBBP SHANK2 CLBA1	9.26e-05	198	121	7	3854_DN
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; PC3; HT_HG-U133A	TSC22D2 ARHGAP35 EMSY SHANK2 XYLB ZNF839 PIGO	9.55e-05	199	121	7	7134_UP
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A	ATXN2L TSC22D2 WNK1 EMSY ARAP3 SUPT6H PIGO	9.55e-05	199	121	7	2550_DN
Drug	Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; HL60; HG-U133A	TGIF2 PPP1R12B RUNX1T1 CIC CASZ1 ANKRD11 ZNF839	9.55e-05	199	121	7	1719_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A	EPHB3 FN1 KAT2A TNFRSF10B CIC EMSY PCNX2	9.55e-05	199	121	7	5534_DN
Drug	Glipizide [29094-61-9]; Down 200; 9uM; PC3; HT_HG-U133A	HSPG2 FN1 SRCAP LDLR JAK2 XYLB CFAP69	9.55e-05	199	121	7	6645_DN
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	FN1 DBF4B TSC22D2 ARHGAP35 DLK2 MUC5AC PIGO	9.55e-05	199	121	7	6634_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A	TGIF2 PPP1R12B KAT2A TSC22D2 SRCAP CIC CASKIN2	9.55e-05	199	121	7	7170_DN
Drug	Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A	HSPG2 CACNB1 PPP1R12B DLK2 TNS1 HCLS1 LILRA4	9.55e-05	199	121	7	3934_UP
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	DBF4B MUC5B TNFRSF10B ARHGAP35 PCNX2 ATXN2 XYLB	9.55e-05	199	121	7	3684_DN
Drug	Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; HL60; HT_HG-U133A	EPHB3 FN1 KAT2A SRCAP CASZ1 EMSY CAMKMT	9.85e-05	200	121	7	3130_UP
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A	ANK2 KAT2A RUNX1T1 SHANK2 PPP1R37 TNS1 MUC6	9.85e-05	200	121	7	3760_UP
Drug	bromfenacoum	ATXN2L PPP1R12B LARP1 TSG101 SPECC1 TSC22D1 GTF3C2 ATXN2 TJP1 CTNND2 BSN MTUS2	1.67e-04	644	121	12	ctd:C013418
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; HL60; HT_HG-U133A	NCOA3 TNFRSF10B KDM6B LDLR CFAP69 VCPIP1	2.09e-04	159	121	6	2192_UP
Drug	Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; HL60; HT_HG-U133A	FN1 LARP1 ARHGAP35 LDLR LRP8 GTF3C2	2.56e-04	165	121	6	2145_DN
Drug	AC1L1C2F	HSPG2 FN1 COL27A1 LAMP3 MUC5AC	3.06e-04	110	121	5	CID000001711
Drug	0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A	ATXN2L TSC22D2 SRCAP DLK2 HCLS1 VCPIP1	3.95e-04	179	121	6	3630_UP
Drug	0179445-0000 [211246-22-9]; Up 200; 10uM; MCF7; HT_HG-U133A	EPHB3 TNFRSF10B SRCAP CREBBP GTF3C2 MAP3K13	4.58e-04	184	121	6	4755_UP
Drug	Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	CASZ1 GAS2L1 TSC22D1 SHANK2 XYLB TNS1	4.58e-04	184	121	6	2946_UP
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	HSPG2 SRCAP LDLR PCNX2 LAMP3 ZMYM6	4.84e-04	186	121	6	1533_UP
Drug	Salbutamol [18559-94-9]; Up 200; 16.8uM; HL60; HT_HG-U133A	NCOA3 FN1 KDM6B EMSY ZCCHC14 CELSR3	4.98e-04	187	121	6	2344_UP
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	FN1 DBF4B WNK1 ADAMTS12 MUC5AC PLCE1	5.27e-04	189	121	6	2231_UP
Drug	Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A	FN1 TSC22D1 SHANK2 CELSR3 TNS1 LILRA4	5.27e-04	189	121	6	3084_UP
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A	ATXN2L HSPG2 SUPT6H XYLB CTNND2 CFAP69	5.27e-04	189	121	6	4304_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	DBF4B ARHGAP35 WNK1 CASKIN2 CFAP69 ZMYM6	5.42e-04	190	121	6	4582_DN
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	EPHB3 DLG5 PLK2 SHANK2 GTF3C2 MUC5AC	5.42e-04	190	121	6	7528_DN
Drug	Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A	EPHB3 NCOA3 TGIF2 TNFRSF10B PCNX2 PIGO	5.42e-04	190	121	6	7145_DN
Drug	Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A	EPHB3 FN1 SRCAP EMSY TNS1 PIGO	5.57e-04	191	121	6	7547_UP
Drug	Butamben [94-25-7]; Down 200; 20.6uM; PC3; HT_HG-U133A	PLK2 FN1 DBF4B TNFRSF10B SRCAP SUPT6H	5.57e-04	191	121	6	5792_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	ATXN2L DBF4B WNK1 GAS2L1 CAMKMT TNS1	5.57e-04	191	121	6	3815_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HG-U133A	TNFRSF10B WNK1 CREBBP CIC WDR13 TNS1	5.73e-04	192	121	6	611_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	FN1 TNFRSF10B CELSR3 SETBP1 DLK2 TNS1	5.73e-04	192	121	6	6664_DN
Drug	ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A	HSPG2 ANK2 SRCAP XYLB MAP3K13 MUC6	5.73e-04	192	121	6	4429_UP
Disease	Neurodevelopmental Disorders	ANK2 SRCAP SETBP1 PAK1 ANKRD11 RIMS1 DNM1	1.03e-07	93	119	7	C1535926
Disease	spinocerebellar ataxia type 2 (implicated_via_orthology)	ATXN2L ATXN2	1.61e-05	2	119	2	DOID:0050955 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	NCOA3 FN1 ANK2 PPP1R12B OBSCN MAGEE1 WNK1 CIC EMSY ZCCHC14 ARAP3 SETBP1 PAK1 MAP3K13 TNS1	2.85e-05	1074	119	15	C0006142
Disease	pulse pressure measurement	GATAD2A FN1 ANK2 RBM33 COL27A1 TSC22D2 KDM6B SRCAP CASZ1 FNDC1 SUPT6H ANKRD11 CTNND2 MBD5 CFAP69 NPNT PLCE1	4.40e-05	1392	119	17	EFO_0005763
Disease	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	CSF3R SETBP1	4.83e-05	3	119	2	C1292772
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	4.83e-05	3	119	2	DOID:9368 (is_marker_for)
Disease	Leukemia, Myelocytic, Acute	RUNX1T1 CREBBP JAK2 GAS2L1 CSF3R SETBP1	7.47e-05	173	119	6	C0023467
Disease	Crohn's disease	ANK2 MUC19 EMSY IGLV3-21 JAK2 CELSR3 ATXN2 SYVN1 BSN	7.78e-05	441	119	9	EFO_0000384
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	1.22e-04	24	119	3	DOID:12894 (is_marker_for)
Disease	Colorectal Carcinoma	CACNB1 FN1 ANK2 OBSCN RUNX1T1 WNK1 ARAP3 SETBP1 DCHS1 CTNND2 PIGO	1.32e-04	702	119	11	C0009402
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC5AC MUC6	1.33e-04	64	119	4	DOID:4947 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC5AC MUC6	1.60e-04	5	119	2	DOID:3030 (is_marker_for)
Disease	Myeloid Leukemia, Chronic	JAK2 CSF3R SETBP1	2.16e-04	29	119	3	C0023473
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	CELSR3 BSN	3.34e-04	7	119	2	EFO_0020797
Disease	autism spectrum disorder (implicated_via_orthology)	TMPRSS9 CREBBP SHANK2 RIMS1 CTNND2	3.87e-04	152	119	5	DOID:0060041 (implicated_via_orthology)
Disease	Agents acting on the renin-angiotensin system use measurement	TSC22D2 KDM6B LDLR CASZ1 SAP130 NPNT PLCE1	4.32e-04	335	119	7	EFO_0009931
Disease	level of Triacylglycerol (49:2) in blood serum	GATAD2A GTF3C2	4.44e-04	8	119	2	OBA_2045162
Disease	inflammatory bowel disease	ATXN2L MUC19 KAT2A EMSY JAK2 CELSR3 ATXN2 BSN	4.86e-04	449	119	8	EFO_0003767
Disease	cortical thickness	HSPG2 GATAD2A CHSY1 TSC22D2 ARHGAP35 RUNX1T1 SPECC1 LRP8 ZNF469 ATXN2 ROBO2 TNS1 PLCE1	5.65e-04	1113	119	13	EFO_0004840
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	7.11e-04	10	119	2	DOID:10140 (is_marker_for)
Disease	blood cobalt measurement	MUC16 ROBO2 USH2A TNS1	7.60e-04	101	119	4	EFO_0007577
Disease	pulmonary fibrosis	MUC5B MUC5AC	8.66e-04	11	119	2	EFO_0009448
Disease	mean arterial pressure	PLK2 HM13 CASZ1 ARAP3 ATXN2 TNS1 NPNT PLCE1	9.64e-04	499	119	8	EFO_0006340
Disease	Amyotrophic Lateral Sclerosis, Familial	CREBBP LDLR OTOG	9.69e-04	48	119	3	C4551993
Disease	Amyotrophic Lateral Sclerosis, Sporadic	CREBBP LDLR OTOG	9.69e-04	48	119	3	C1862941
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L ATXN2	1.04e-03	12	119	2	DOID:1441 (implicated_via_orthology)
Disease	AMYOTROPHIC LATERAL SCLEROSIS 1	CREBBP LDLR OTOG	1.09e-03	50	119	3	C1862939
Disease	Tourette syndrome	COL27A1 MUC16 RUNX1T1	1.09e-03	50	119	3	EFO_0004895
Disease	Acute Cerebrovascular Accidents	ANK2 CASZ1 ZCCHC14	1.37e-03	54	119	3	C0751956
Disease	Small cell carcinoma of lung	EPHB3 RUNX1T1 CREBBP	1.37e-03	54	119	3	C0149925
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	1.42e-03	14	119	2	DOID:10808 (implicated_via_orthology)
Disease	leukemia	NCOA3 JAK2 CSF3R	1.44e-03	55	119	3	C0023418
Disease	Cerebrovascular accident	ANK2 CASZ1 ZCCHC14	2.03e-03	62	119	3	C0038454
Disease	cystic fibrosis (is_marker_for)	MUC5B CSF3R MUC5AC	2.03e-03	62	119	3	DOID:1485 (is_marker_for)
Disease	bitter alcoholic beverage consumption measurement	KDM6B CIC XYLB ARMH4	2.10e-03	133	119	4	EFO_0010092
Disease	skin pigmentation measurement	TNFRSF10B ADAMTS12 ANKRD11 USH2A	2.34e-03	137	119	4	EFO_0007009
Disease	blood urea nitrogen measurement	FCHO2 CASZ1 ATXN2 SETBP1 WDR90 MBD5 PLCE1	2.43e-03	452	119	7	EFO_0004741
Disease	Profound Mental Retardation	KDM6B CIC SHANK2 SETBP1	2.46e-03	139	119	4	C0020796
Disease	Mental Retardation, Psychosocial	KDM6B CIC SHANK2 SETBP1	2.46e-03	139	119	4	C0025363
Disease	Mental deficiency	KDM6B CIC SHANK2 SETBP1	2.46e-03	139	119	4	C0917816
Disease	skin sensitivity to sun	ADAMTS12 ANKRD11	2.64e-03	19	119	2	EFO_0004795
Disease	factor VIII measurement, Ischemic stroke	FCHO2 ATXN2	2.64e-03	19	119	2	EFO_0004630, HP_0002140
Disease	Abdominal Aortic Aneurysm	LDLR JAK2 LRRN4	2.65e-03	68	119	3	EFO_0004214
Disease	stroke	ANK2 CASZ1 ADAMTS12 ATXN2	2.80e-03	144	119	4	EFO_0000712
Disease	mean platelet volume	ARGFX TSC22D2 FCHO2 SRCAP JAK2 GORASP2 ATXN2 SETBP1 ANKRD11 PLCE1 RNF212B	2.82e-03	1020	119	11	EFO_0004584
Disease	cortisol measurement	TMPRSS9 LDLR	2.92e-03	20	119	2	EFO_0005843
Disease	Autoimmune Hepatitis	ATXN2 LILRA4	3.22e-03	21	119	2	EFO_0005676
Disease	rheumatoid arthritis, ulcerative colitis	EMSY JAK2	3.22e-03	21	119	2	EFO_0000685, EFO_0000729
Disease	pentachlorophenol measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022071
Disease	parathion measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022070
Disease	potassium chromate measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022072
Disease	mercuric chloride measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022068
Disease	heptachlor epoxide measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022067
Disease	methoxychlor measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022052
Disease	azinphos methyl measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022055
Disease	aldrin measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022054
Disease	dicofol measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022060
Disease	disulfoton measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022062
Disease	dieldrin measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022061
Disease	endrin measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022064
Disease	endosulfan measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022063
Disease	heptachlor measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022066
Disease	ethion measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022065
Disease	chlorpyrifos measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022057
Disease	cadmium chloride measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022056
Disease	diazinon measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022059
Disease	dibutyl phthalate measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0022058
Disease	environmental exposure measurement	MUC16 USH2A TNS1	3.24e-03	73	119	3	EFO_0008360
Disease	eosinophil percentage of leukocytes	POU2AF1 KDM6B WNK1 EMSY JAK2 CSF3R ATXN2 MBD5 MUC5AC	3.30e-03	746	119	9	EFO_0007991
Disease	DDT metabolite measurement	MUC16 USH2A TNS1	3.37e-03	74	119	3	EFO_0007886
Disease	reticulocyte measurement	GATAD2A LARP1 TSC22D2 KDM6B SPECC1 ZNF469 ATXN2 SETBP1 BSN TNS1 ARMH4	3.59e-03	1053	119	11	EFO_0010700
Disease	Renal glomerular disease	CREBBP PLCE1	3.86e-03	23	119	2	C0268731
Disease	Glomerulopathy Assessment	CREBBP PLCE1	3.86e-03	23	119	2	C4521256
Disease	schizophrenia (is_implicated_in)	LRP8 PAK1 CTNND2	3.90e-03	78	119	3	DOID:5419 (is_implicated_in)
Disease	neuroimaging measurement	ATXN2L GATAD2A TSC22D2 ARHGAP35 RUNX1T1 LRP8 ZNF469 ATXN2 ROBO2 TNS1 PLCE1	4.02e-03	1069	119	11	EFO_0004346

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPVTSRTPGVVASAP	EP400	736	Q96L91
VPAAVVSSPGVTTLP	EP400	2921	Q96L91
SPLLVGPVSVSFSPV	B4GALT3	81	O60512
QISAPTPALRPTTGT	ARAP3	181	Q8WWN8
DQSRPTGVPTPTSVL	ANKRD11	1696	Q6UB99
DVVTGTRRPTPPASA	CACNB1	196	Q02641
PVTTATVSSLEGPAP	CASZ1	1091	Q86V15
PSPVSDVPGVTQLSR	ARMH4	501	Q86TY3
ANTPTVGVSRGPSPV	FCHO2	521	Q0JRZ9
LPGSTDPPTSASRVA	ARGFX	56	A6NJG6
TIPTAAPPSSTGVRK	CREBBP	576	Q92793
FPSVARTQPPTTVST	CREBBP	1921	Q92793
VSRTSPTPPESATTV	SPECC1	806	Q5M775
VSSAGLSPIRVTSPP	CTNND2	321	Q9UQB3
ETSRAAVPPGTVVPT	ARMCX2	171	Q7L311
LPSQRPTTSETGTPR	ADAMTS12	1221	P58397
PIGSAVPTSSASIPV	ATXN2L	466	Q8WWM7
AGRVAPPASSSVTAP	MTUS2	906	Q5JR59
TSSPTRRVSFVPPVT	MUC5B	46	Q9HC84
SPGLTRAPPASTTAV	MUC5B	1636	Q9HC84
PGVATSTLPTRSALP	MUC5B	1686	Q9HC84
VTPSSALGTTHTPPV	MUC5B	2176	Q9HC84
SITPRPVGITSPSQS	RNF212B	146	A8MTL3
PIVSASPPSRAVAGS	RBM33	736	Q96EV2
PAGSTQPIRIEPSSS	HSPG2	2336	P98160
GVSDVPTSPTLQRPT	JAK2	516	O60674
VSAAVVPSTPIFSPS	KAT2A	396	Q92830
QGTTPDTTPARTPTE	ANK2	3076	Q01484
GSVGSTVTTPPPLVR	GATAD2A	181	Q86YP4
PPSVSVSPGQTARIT	IGLV3-25	26	P01717
EASSAIPTPTVSPGV	MUC16	10916	Q8WXI7
EASSTVPTVSPEVPG	MUC16	11026	Q8WXI7
ASSAVPTPTVSPGVS	MUC16	11081	Q8WXI7
TTLPVAITSPGPEAS	MUC16	11516	Q8WXI7
GVDTRSGVPTTTIPP	MUC16	11611	Q8WXI7
ATQTTGPRPTPASTT	MUC6	1356	Q6W4X9
RSTSPIIGSPPVRAV	PATL1	176	Q86TB9
GPLPGSRSATVPVTV	DCHS1	2906	Q96JQ0
GAPEPSTIARSLPTT	LARP1	756	Q6PKG0
SDRPSLSVQPGPTVT	LILRA4	321	P59901
PTRGKGSSTSVPPTA	MAGEE1	286	Q9HCI5
PAVSSVLSTGVPTVP	GORASP2	266	Q9H8Y8
PPSVSVSPGQTARIT	IGLV3-10	26	A0A075B6K4
TPERPTTGLTTIAPA	NPNT	346	Q6UXI9
ATPRSTTPGTPSTIE	RUNX1T1	586	Q06455
QSVPAGRRSPTSSPT	DNM1	766	Q05193
SEAATPPVARTSPSG	ATXN2	656	Q99700
APVPSGTSTPTLVAE	KIAA2026	1511	Q5HYC2
TGAAVSTRPGPLPTT	KDM6B	821	O15054
SSVPGTSRVEPGPRT	BSN	1646	Q9UPA5
IAPVVSSRVSPGTRP	ARNTL2	21	Q8WYA1
TTPSVPSLRGAAPRS	FAM104A	46	Q969W3
SQPPPVTTTGHLSVR	PCNX2	1996	A6NKB5
PAAVTGTIRPSAVVT	MUC19	4596	Q7Z5P9
PAAVTGTTRPSAVVT	MUC19	4856	Q7Z5P9
TRPSAGITATTGVPA	MUC19	6111	Q7Z5P9
RTATTGVAPGTTVAP	MUC19	6766	Q7Z5P9
ASPVPTPAVSRTLLG	FAM214B	336	Q7L5A3
TSRPPATPAGVRFVS	INTS2	416	Q9H0H0
SRPSVGTVPRSLTPS	DLG5	1171	Q8TDM6
PPSVSVAPGQTARIT	IGLV3-21	26	P80748
CTTVPSPPRGVISNV	EPHB3	336	P54753
TAPPVTEVTVGPSLA	LAMP3	116	Q9UQV4
TTRTAAPASTVPGPT	LAMP3	201	Q9UQV4
STTRPPSTPEGIALA	HM13	21	Q8TCT9
PTTAGTSPRTRLPTA	MUC5AC	1361	P98088
TVATTRPTPHPTGAQ	MUC5AC	1686	P98088
PGTVSLSTARTTPAP	MUC5AC	1886	P98088
TPVTAPSTPSGRATS	MUC5AC	3331	P98088
VTAPSTPSGRATSPT	MUC5AC	3631	P98088
STPVTAPSTPSGRAT	MUC5AC	4061	P98088
SALVRTSPSVTPTPA	CASKIN2	836	Q8WXE0
PGSPSTPTEQRISVS	PPP1R37	546	O75864
RPSISVISPTSPGAL	RIMS1	721	Q86UR5
ASIPGTPPTAGRVVS	GPR149	236	Q86SP6
PASPPSTGTRTCTVT	OBSCN	236	Q5VST9
GIPTTEVAPTASPLS	MAP3K13	556	O43283
VTTRSSATPAVGPPL	POU2AF1	151	Q16633
VTPTRDVATSPISPT	PAK1	211	Q13153
RDPTVPGPTSSATNV	NBPF3	41	Q9H094
GCPSPSPSEVRVETS	DBF4B	106	Q8NFT6
QETTGTPRSDTVPSP	FN1	896	P02751
SRVSSPSPELGTTPA	GAS2L1	486	Q99501
LPPRSAATVSPVAGT	FNDC1	1261	Q4ZHG4
TSGTSTPRTAPAVPT	COL27A1	511	Q8IZC6
TSRPTPVVFSESRGP	CSF3R	416	Q99062
GTNATPVVPSRAATP	MBD5	131	Q9P267
TPVPSGSIATVKSPR	EMSY	156	Q7Z589
DTPLGPTSAVVVPAT	DLK2	261	Q6UY11
PSATASVLGPSTPRS	CELSR3	3276	Q9NYQ7
VPSGGVVTVESTPAR	CFAP69	886	A5D8W1
SPVSSPSVSGPRRLV	SPACA3	16	Q8IXA5
TPVTRVGSAAPSRSP	FAM8A1	216	Q9UBU6
TRTVPATTRAPGTTV	LRP8	751	Q14114
GTTVAPSAAPATRPA	LRRN4	386	Q8WUT4
SSRPVASPGAISRSP	OTOG	1656	Q6ZRI0
VTPGTQSSPAPSTRT	SYTL5	256	Q8TDW5
TVLASLGPPRPATSV	SYVN1	526	Q86TM6
PRLSVGSVTSRPSTP	TAF9	146	Q16594
GAAPQSVPTPSRVRS	USH2A	1951	O75445
GTSPVPSVRSLRSEP	TMEM200B	196	Q69YZ2
AAVPAPSVPSVSTTS	TSC22D2	511	O75157
VGTPPSSESEPVRTS	HCLS1	306	P14317
AAGTSSPIRPVSSPV	PLCE1	1161	Q9P212
VSLDSPVSVGSSPPV	NCOA3	856	Q9Y6Q9
RPPGSVVPTSAAEAS	WDR13	131	Q9H1Z4
SASITGGPPSSPVSR	TSC22D1	246	Q15714
TATATTTAVPAPTPA	SRCAP	1151	Q6ZRS2
QPSTGVARPTVSSGP	SPTY2D1	381	Q68D10
GARPSSPSAVASTVP	ARHGAP35	1446	Q9NRY4
PRGSSPSVLAVSVPA	TGIF2	106	Q9GZN2
ISAAPEPTTVPGRTI	SHANK2	1361	Q9UPX8
TSGTRRAPSPVVSPT	SHANK2	1701	Q9UPX8
AAPSGPAPTTSIRFT	CIC	851	Q96RK0
PAVGCTTRGPVVSAP	CAMKMT	21	Q7Z624
SSEGSDTSVPIPVVP	CHSY1	121	Q86X52
VTGTSAVPPSEPILS	CLBA1	131	Q96F83
SQPPVTTVGPSRDGT	TSG101	206	Q99816
QDPVPGITPSSSSRT	SUPT6H	1516	Q7KZ85
PVVQTPSPTASGRAA	WDR90	271	Q96KV7
SQTSAPTVSPVTRPR	nan	96	P0C879
PATRATRESPGTSLP	TMPRSS13	141	Q9BYE2
TSTVLPRSASAPGAP	SOWAHA	106	Q2M3V2
GAVPITPPITTIAAA	SAP130	746	Q9H0E3
TIAAAPPPSVTVGGS	SAP130	756	Q9H0E3
TSPRSPGVRSPVQCV	TNS1	911	Q9HBL0
SPPVPSCSVVGAISS	XYLB	246	O75191
TVSITRTPPRASPTG	nan	306	Q9UF83
PRTTAGLTVPGATPS	TMPRSS9	756	Q7Z410
TPPVRGVASSPAISF	ROBO2	1131	Q9HCK4
VPAVEETVTSSPGTP	TNFRSF10B	191	O14763
VSPSTIRDGPSSAPA	VCPIP1	746	Q96JH7
AGFSPPVNVTVSPRS	ZNF839	526	A8K0R7
TSPPLAGAVSPSVAV	ZNF469	2241	Q96JG9
VGTPPESAITRSSEP	TJP1	866	Q07157
SAPPLVTSSGVARVP	ZCCHC14	366	Q8WYQ9
VVSPPSSRSAVSIGG	ZMYM6	376	O95789
TRTVLTPFSGPPTSQ	PIGO	776	Q8TEQ8
EPVVPRSTPRGSTSG	GTF3C2	271	Q8WUA4
QPPTTTVARSGTPAV	PLK2	421	Q9NYY3
VPPFLSSIAGVPTTA	WNK1	1336	Q9H4A3
STVTPGIPTTAVAPS	WNK1	1686	Q9H4A3
SEATATRPAVPGLPT	TCTN3	51	Q6NUS6
VVPTLVTPSAPGNRT	TCTN3	66	Q6NUS6
STSPVSPISREFPGT	SETBP1	606	Q9Y6X0
TTTRPVPDTSRLPGA	LDLR	741	P01130
VATATTPPPARSATS	MUC12	481	Q9UKN1
AVVVASPRPRTPVGS	RAB34	91	P0DI83
GPSSPVVVRLPSVSD	MYO9A	2291	B2RTY4
RPLPSTANGVTATPV	PPP1R12B	586	O60237